RE: Is this citation from Cryocor right?Three things : (1) no mention anywhere, in the PR, that the trial is actually for left side AF (2) even if the trial is for left side ablation, their method is still point to point (no balloon), and much slower, meaning increased radiation exposure for the interventionist (3) Cryocor's efficay numbers are inferior to Crocath's, and some who post here, including me, were stunned that they received FDA approval. Still worried ? Think about Europe, where Cryocor has been approved for over two years, yet have virtually no sales traction, for good reason.